Symbols

LUNG

Pulmonx·NASDAQ

--(--)

LUNG Profile

Pulmonx Corporation

A global leader in minimally invasive treatments for severe lung disease

Industry

Healthcare Equipment and Supplies

Established Date

12/26/1995

Listing Date

10/01/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

296

Fiscal Year Ends

12-31

Website

www.pulmonx.com

Security Type

Common stock

Office address

700 Chesapeake Drive, Redwood City, California 94063

Business

Introduction

Pulmonx Corporation was incorporated in California as Pulmonx on December 26, 1995 and re-incorporated in Delaware on December 4, 2013. The company is a commercial-stage medical technology company that provides minimally invasive treatment for patients with severe emphysema, a chronic obstructive pulmonary disease. The company's solutions, consisting of the Zephyr Endobronchial Valve, the Chartis Lung Assessment System and the LungTraX platform, are designed to treat a large number of patients whose medical management has reached the limit, does not want or is not eligible for surgery. The company has subsidiaries in Germany, Switzerland, Australia, the United Kingdom, Italy, France, Hong Kong and Japan.